Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4QHM0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.508 |
CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.410 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 161 | 163 | PF00082 | 0.548 |
CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.456 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.439 |
DOC_MAPK_gen_1 | 126 | 135 | PF00069 | 0.591 |
DOC_MAPK_gen_1 | 7 | 16 | PF00069 | 0.633 |
DOC_MAPK_MEF2A_6 | 128 | 137 | PF00069 | 0.466 |
DOC_MAPK_MEF2A_6 | 7 | 16 | PF00069 | 0.602 |
DOC_MAPK_RevD_3 | 109 | 124 | PF00069 | 0.657 |
DOC_PP4_FxxP_1 | 122 | 125 | PF00568 | 0.657 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.747 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.459 |
DOC_USP7_UBL2_3 | 161 | 165 | PF12436 | 0.345 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.725 |
DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.666 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.714 |
LIG_14-3-3_CanoR_1 | 95 | 103 | PF00244 | 0.627 |
LIG_BRCT_BRCA1_1 | 133 | 137 | PF00533 | 0.317 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.632 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.648 |
LIG_LIR_Gen_1 | 117 | 125 | PF02991 | 0.661 |
LIG_LIR_LC3C_4 | 31 | 34 | PF02991 | 0.650 |
LIG_LIR_Nem_3 | 117 | 122 | PF02991 | 0.732 |
LIG_LYPXL_L_2 | 61 | 70 | PF13949 | 0.639 |
LIG_NRP_CendR_1 | 180 | 181 | PF00754 | 0.685 |
LIG_Pex14_2 | 137 | 141 | PF04695 | 0.379 |
LIG_SH2_SRC | 19 | 22 | PF00017 | 0.684 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.620 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.706 |
LIG_SH3_3 | 143 | 149 | PF00018 | 0.403 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.699 |
LIG_SUMO_SIM_anti_2 | 44 | 50 | PF11976 | 0.636 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.384 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.687 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.684 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.673 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.479 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.473 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.695 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.718 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.671 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.694 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.698 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.727 |
MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.665 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.715 |
MOD_SUMO_rev_2 | 64 | 70 | PF00179 | 0.679 |
TRG_DiLeu_BaEn_1 | 44 | 49 | PF01217 | 0.632 |
TRG_ER_diArg_1 | 125 | 128 | PF00400 | 0.643 |
TRG_ER_diArg_1 | 86 | 88 | PF00400 | 0.676 |
TRG_NLS_MonoCore_2 | 122 | 127 | PF00514 | 0.668 |
TRG_NLS_MonoExtC_3 | 160 | 165 | PF00514 | 0.359 |
TRG_Pf-PMV_PEXEL_1 | 88 | 92 | PF00026 | 0.485 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JHE9 | Bodo saltans | 62% | 100% |
A0A1X0NID1 | Trypanosomatidae | 63% | 96% |
A0A3R7KNE8 | Trypanosoma rangeli | 62% | 96% |
A0A3S5H6F1 | Leishmania donovani | 92% | 100% |
A4H5Y2 | Leishmania braziliensis | 84% | 100% |
A4HU78 | Leishmania infantum | 91% | 100% |
D0A9R0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 73% |
E9AN08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |